Please login to the form below

Not currently logged in
Email:
Password:

UK women 'unaware' of HPV cancer link

According to research published in the British Journal of Cancer, a large majority of UK women did not know that most cervical cancer is caused by a sexually transmitted infection.

According to research published in the British Journal of Cancer, a large majority of UK women did not know that most cervical cancer is caused by a sexually transmitted infection.

In a survey of 1,600 women, only 2.5 per cent cited human papillomavirus (HPV) as a risk factor for cervical cancer. Researchers said the results were "striking" considering recent publicity over the development of a HPV vaccine.

Merck & Co's Gardasil and GlaxoSmithKline's (GSK) Cervarix HPV vaccines have both demonstrated efficacy against the strains most commonly linked with cervical cancer. Gardasil reached market first.

In June 2007, advisors to the UK government recommended vaccinating girls aged between 12 and 13 years and also suggested that HPV testing should be combined with cervical screening.

The survey which was performed at the beginning of 2007 showed a three-fold increase in the number of women who were able to list HPV as a cause of the infection - but the figure is still "extraordinarily low", concluded the researchers.

13th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics